Euthatal Solution for Injection 200 mg in 1 ml
Pentobarbital Sodium
Last verified
Veterinary medicinal product: solution for injection. Distribution category: POM-V (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Pentobarbital Sodium.1
In short: questions and answers
- Does Euthatal Solution for Injection 200 mg in 1 ml need a prescription?
- Prescription only. As stated in the registration decision.1
- Which animals is Euthatal Solution for Injection 200 mg in 1 ml for?
- Cats, Dogs, Small Mammals.1
- What is the active substance in Euthatal Solution for Injection 200 mg in 1 ml?
- Pentobarbital Sodium. ATCvet code: QN51AA01.13
- What is the withdrawal period of Euthatal Solution for Injection 200 mg in 1 ml according to the leaflet?
- No withdrawal period is set for this drug: it is not intended for food-producing animals.3
- Dispensing
- Prescription only1
POM-V: Prescription Only Medicine - Veterinarian. Supplied only on a prescription written by a veterinary surgeon who has assessed the animal.12
Supplied only on a veterinarian's prescription. As stated in the registration decision.
- Active substance
- Pentobarbital Sodium
- ATCvet code
- QN51AA013
- Manufacturer
- Marketing authorisation holder: Duggan Veterinary Supplies Limited
Withdrawal period
No withdrawal period is set for this drug: it is not intended for food-producing animals.3
Summary of product characteristics
Composition
Each ml contains:
Active Substance
Pentobarbital sodium 200mg
Excipients
Patent Blue V (E131) 0.01mg
For full list of excipients, see section 6.1.
6.1 List of excipients
Propylene Glycol
Ethanol
Patent Blue V (E131)
Water for Injections
Pharmaceutical form
Blue aqueous solution for injection.
Pharmacological properties
ATC Vet Code:
QN51AA01
5.1 Pharmacodynamic properties
The major action of barbiturates is to depress the central nervous system (CNS). All degrees of depression, ranging from mild sedation to general anaesthesia and ultimately death are induced depending upon dosage. The dosage for euthanasia is 140-150 mg/kg, death occurs due to respiratory failure.
5.2 Pharmacokinetic properties
No data available.
Target species
Dogs, cats and other small animals.
Indications
Euthanasia in dogs, cats and other small animals.
Dosage
The product is primarily intended for and is most consistently effective when administered by intravenous route.
The solution should be administered at the rate of 1ml per 1.4kg (3lb) bodyweight (approximately 150mg/kg bodyweight) as quickly as possible.
Contraindications
Do not use for anaesthetic purposes.
Carcasses of animals, which have been euthanised with the product, must not be used for animal consumption.
Do not administer by intramuscular route.
Adverse reactions
Not applicable.
Warnings
(i) Special precautions for use in animals.
In the event of accidental administration to an animal not presented for euthanasia, measures such as artificial respiration, administration of oxygen, and the use of analeptics are appropriate.
(ii) Special precautions to be taken by the person administering the medicinal product to the animals In the case of accidental self-administration, seek urgent medical attention, advising medical service of barbiturate poisoning. Pentobarbital is a potent drug, which is toxic to man. Particular care should be taken to avoid accidental ingestion and self-injection.
In the event of an accident the following action should be taken:
Skin - Wash immediately with water and then thoroughly with soap and water.
Eyes - Wash immediately with cold water and obtain medical attention. Ingestion - Obtain medical attention immediately. Wash out mouth. Keep warm and rest.
Accidental self injection - Obtain URGENT medical attention, advising medical services of barbiturate poisoning. Do not leave patient unattended.
Advice to Doctor: Maintain airways and give symptomatic and supportive treatment.
Use during pregnancy, lactation or lay
Not applicable.
Interactions
None known. The product is intended for use alone.
Overdose
Not applicable.
Special warnings
In some circumstances the intrathoracic or intracardiac routes of administration may be used, but only as a last resort. The choice of these routes should be made in the light of the attendant difficulties and the unnecessary pain and distress to the animal which could result. When it is anticipated that euthanasia may be problematical (e.g. aggressive patients), premedication with appropriate sedative is recommended.
Withdrawal period
Not applicable. Not to be used in animals intended for human consumption.
Incompatibilities
Do not dilute with water or any other fluid.
Immediate packaging
Amber, Type II vials with rubber (6BU) chlorobutyl bung containing 100ml.
Storage
Do not store above 25oC. Protect from light.
Discard if any sediment is observed.
The product does not contain an antimicrobial preservative.
This product is not sterile.
Shelf life
3 years.
Following withdrawal of the first dose, use the product within 28 days. Discard unused material.
Disposal of unused product
Any unused product or waste material should be disposed of in accordance with national requirements.
UK only: Disposal of this product is controlled by the Misuse of Drugs Regulation 2001 in the UK.
Additional information
Vm 61058/5000
9 DATE OF FIRST AUTHORISATION
20 September 1993
10 DATE OF REVISION OF THE TEXT
June 2025
Registration holder
Duggan Veterinary Supplies Limited
Unit 9 Thurles Retail Park
Thurles
Co.Tipperary
Ireland
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32
Sources
- VMD Product Information Database: Euthatal Solution for Injection 200 mg in 1 ml, 61058/5000
- The Veterinary Medicines Regulations 2013, Schedule 3 (categories of veterinary medicinal products)
- Summary of Product Characteristics: Euthatal Solution for Injection 200 mg in 1 ml